Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018 - Archive ouverte HAL Access content directly
Journal Articles Eurosurveillance Year : 2021

Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018

(1, 2) , (1, 2) , (1, 2) , (1, 2) , (1, 3) , , (1, 2, 4, 5) , (1, 2)
1
2
3
4
5

Abstract

Background: Bordetella pertussis is the main agent of whooping cough. Vaccination with acellular pertussis vaccines has been largely implemented in high-income countries. These vaccines contain 1 to 5 antigens: pertussis toxin (PT), filamentous haemagglutinin (FHA), pertactin (PRN) and/or fimbrial proteins (FIM2 and FIM3). Monitoring the emergence of B. pertussis isolates that might partially escape vaccine-induced immunity is an essential component of public health strategies to control whooping cough. Aim: We aimed to investigate temporal trends of fimbriae serotypes and vaccine antigenexpression in B. pertussis over a 23-year period in France (1996-2018). Methods: Isolates (n = 2,280) were collected through hospital surveillance, capturing one third of hospitalised paediatric pertussis cases. We assayed PT, FHA and PRN production by Western blot (n = 1,428) and fimbriae production by serotyping (n = 1,058). Molecular events underlying antigen deficiency were investigated by genomic sequencing.
Fichier principal
Vignette du fichier
FINAL_APPROVED_20-01213_BRISSE_Pertussis.pdf (768.21 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-03349287 , version 1 (20-09-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Valérie Bouchez, Sophie Guillot, Annie Landier, Nathalie Armatys, Soraya Matczak, et al.. Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018. Eurosurveillance, 2021, 26 (37), ⟨10.2807/1560-7917.ES.2021.26.37.2001213⟩. ⟨pasteur-03349287⟩
16 View
22 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More